John A Jernigan researcher
Jernigan, John A.
VIAF ID: 88437311 (Personal)
Permalink: http://viaf.org/viaf/88437311
Preferred Forms
- 100 1 _ ‡a Jernigan, John A.
- 100 0 _ ‡a John A Jernigan ‡c researcher
Works
Title | Sources |
---|---|
The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. | |
Current practice in Staphylococcus aureus screening and decolonization | |
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers | |
Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial. | |
The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients: a randomized trial. | |
Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial | |
Effect of daily chlorhexidine bathing on hospital-acquired infection | |
Effect of nonpayment for preventable infections in U.S. hospitals. | |
Enhancement of health department capacity for health care-associated infection prevention through Recovery Act-funded programs. | |
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington | |
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis | |
Evaluation of organizational culture among different levels of healthcare staff participating in the Institute for Healthcare Improvement's 100,000 Lives Campaign | |
Factors Associated With Inter-Hospital Variability of Inpatient Antibiotic Use in a Cohort of US Hospitals | |
Fatal inhalational anthrax in a 94-year-old Connecticut woman | |
Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities | |
Fungal infections associated with contaminated methylprednisolone injections | |
Hand hygiene practices after brief encounters with patients: an important opportunity for prevention | |
Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae | |
Improving the Assessment of Vancomycin‐Resistant Enterococci by Routine Screening | |
Industry-related outbreak of human anthrax. | |
Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities - Detroit, Michigan, March-May 2020 | |
Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study | |
Likelihood of Environmental Contamination of Patient Rooms in Six Acute Care Facilities based on Facility, Unit-Type, and Precautions Status. | |
The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections | |
Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: a retrospective cohort analysis | |
Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty. | |
Modeling regional transmission and containment of a healthcare-associated multidrug-resistant organism | |
Monitoring health care workers after smallpox vaccination: findings from the Hospital Smallpox Vaccination-Monitoring System. | |
Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection | |
A multicenter study on optimizing piperacillin-tazobactam use: lessons on why interventions fail. | |
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017 | |
Mupirocin resistance | |
Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington | |
Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014 | |
Pathology and pathogenesis of bioterrorism-related inhalational anthrax | |
Perceived impact of the Medicare policy to adjust payment for health care-associated infections | |
Perspectives on Federal Funding for State Health Care-Associated Infection Programs: Achievements, Barriers, and Implications for Sustainability | |
The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities | |
Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals | |
The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. | |
Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America | |
Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . | |
The Relationship Between Payer and Risk of Surgical Site Infection Following Cesarean Delivery. | |
Reply to Dinh, et al. | |
A research framework for reducing preventable patient harm | |
Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel | |
Sample Size Estimates for Cluster-Randomized Trials in Hospital Infection Control and Antimicrobial Stewardship | |
SARS clinical features, United States, 2003. | |
Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020 | |
The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California | |
Signs, Symptoms, and Comorbidities Associated With Poor Outcomes Among Residents of a Skilled Nursing Facility With SARS-CoV-2 Infection—King County, Washington | |
Survey of employee knowledge and attitudes before and after a multicenter Veterans' Administration quality improvement initiative to reduce nosocomial methicillin-resistant Staphylococcus aureus infections | |
Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort | |
Systems for rapidly detecting and treating persons with ebola virus disease--United States | |
Targeted versus universal decolonization to prevent ICU infection | |
Things We Do For Good Reasons: Contact Precautions for Multidrug-resistant Organisms, Including MRSA and VRE | |
Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion | |
Transmission of SARS-CoV-2 Involving Residents Receiving Dialysis in a Nursing Home - Maryland, April 2020 | |
Trends in antifungal use in US hospitals, 2006-12 | |
Unnecessary use of central venous catheters: the need to look outside the intensive care unit | |
Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. | |
Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons | |
Vascular Access and Risk of Bloodstream Infection Among Older Incident Hemodialysis Patients | |
Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention | |
Vital signs: improving antibiotic use among hospitalized patients | |
Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014. | |
Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017 |